Tuesday, March 06, 2007

Two meds come under fire.

Panel: Aspirin adds to colon cancer risk

People at average risk for colon cancer shouldn't take aspirin or painkillers like ibuprofen to try to prevent the disease, a federal task force advises, because of the risk of bleeding and other potential health problems. The recommendation for the first time by the U.S. Preventive Services Task Force includes those with a family history of colorectal cancer. The panel said that potential risks of taking more than 300 milligrams a day of aspirin or non-steroidal anti-inflammatory drugs, such as ibuprofen and naproxen — brand names include Motrin, Advil and Aleve — include a higher risk for stroke, intestinal bleeding or kidney failure. Those risks outweigh the potential benefits of preventing cancer, the task force said in Tuesday's issue of the Annals of Internal Medicine.

Courtesy AP

Bonnie - as I have said for years, depending on the individual, aspirin can be extremely beneficial or extremely detrimental.

Tamiflu side effect concerns grow after Japan deaths

Concerns that the influenza drug Tamiflu -- seen as effective against a possible pandemic triggered by bird flu -- may induce fatal side effects are growing in Japan after two people who took it fell to their deaths last month. The deaths, the latest cases of abnormal behavior by those who took Tamiflu, prompted the Health Ministry to issue a warning last week that influenza patients could show psychiatric problems, although it has denied the drug was responsible for them. But the move was too little too late, said a group whose members say they are victims of Tamiflu side effects, which came to light in Japan in 2005 after 12 children died and 32 experienced abnormal behavior after taking the drug.

According to the Health Ministry, 54 people have died so far after taking Tamiflu, and in February, a 14-year-old girl and a boy fell to their deaths from their apartment homes in separate incidents after taking the drug. Neither had left a suicide note. Countries around the world are stockpiling the antiviral drug in case of a human influenza pandemic that experts fear could be sparked by the H5N1 bird flu virus. In November, the U.S. Food and Drug Administration decided to require Roche to put a caution on Tamiflu labels urging close monitoring for abnormal behavior, such as delirium, although it said it was unknown if the drug contributed to the psychiatric problems.

Courtesy Reuters

No comments: